Stephen C. Glover

Insider Reports History

Entity
Individual
Location
108 Dockside Circle, Weston, FL
Signature
/s/ Spencer Brown, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen C. Glover:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Ambrx Biopharma Inc. Director Ordinary Shares 85K $786K $9.24 Jun 7, 2023 Direct
Ambrx Biopharma, Inc. Director Restricted Stock Units 0 $0 $9.82 Mar 7, 2024 Direct
Ambrx Biopharma Inc. Director Stock Option (right to buy) 17.5K May 18, 2023 Direct
PDS Biotechnology Corp Director Employee Stock Option (Right to Buy) 9K Jun 24, 2024 Direct
ZyVersa Therapeutics, Inc. Chief Executive Officer, Director Stock Options 1.63K May 24, 2023 Direct
Ambrx Biopharma, Inc. Director Option to Purchase Common Stock 0 Mar 7, 2024 Direct

Insider Reports Filed by Stephen C. Glover

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PDSB PDS Biotechnology Corp Jun 24, 2024 1 $0 4 Jun 25, 2024 Director
AMAM Ambrx Biopharma, Inc. Mar 7, 2024 4 $0 4 Mar 7, 2024 Director
PDSB PDS Biotechnology Corp Jul 14, 2023 1 $0 4 Jul 17, 2023 Director
ZVSA ZyVersa Therapeutics, Inc. May 24, 2023 1 $0 4 Jul 18, 2024 Chief Executive Officer, Director
AMAM Ambrx Biopharma Inc. May 18, 2023 3 $0 4 Jun 9, 2023 Director
AMAM Ambrx Biopharma Inc. May 18, 2023 1 $0 4 May 26, 2023 Director
AMAM Ambrx Biopharma Inc. May 18, 2023 0 $0 3 May 19, 2023 Director
ZVSA ZyVersa Therapeutics, Inc. Dec 12, 2022 14 $0 4 Dec 14, 2022 Chief Executive Officer, Director
ZVSA ZyVersa Therapeutics, Inc. Dec 12, 2022 0 $0 3 Dec 13, 2022 Chief Executive Officer, Director
PDSB PDS Biotechnology Corp Jun 28, 2022 1 $0 4 Jun 29, 2022 Director
PDSB PDS Biotechnology Corp Jun 15, 2021 2 $50K 4 Jun 17, 2021 Director